Med School: Separating Hype from Hope in Genome Science

Genomic discoveries were supposed to transform medicine and move us to a new vision of preventive health care. But 15 years after the Human Genome Project was complete, that still hasn’t happened. Meanwhile, direct-to-consumer genetics companies are bypassing health care providers to market ancestry, disease risk, diet, exercise and even dating and wine applications directly to the public. Robert Green, one of the world’s leaders in generating the evidence-base for genomic medicine, describes what's right and what’s wrong with the genomic revolution, and how we can realize the promise of precision medicine for all.
(Underwritten by America's Biopharmaceutical Companies)

Speakers: Robert C. Green
Festival: Spotlight Health 2018

Watch and Listen: Health

When Big Bird has “big feelings,” he imagines himself in a comfy-cozy nest, soothed by the smell of baking cookies. The... See more
Medical and technological breakthroughs, cultural and demographic upheaval, policy changes, and financial realities... See more
In a wide-ranging interview with PBS anchor Judy Woodruff, best-selling author Atul Gawande explores some of the most... See more
As the nation’s top doctor, the US surgeon general is uniquely positioned to use his bully pulpit to drive Americans... See more
More than one-third of the world’s girls and women have experienced some form of violence in their lives, leading the... See more
The US is aging – between 2012 and 2050, the number of adults over age 60 will jump from 43 to 84 million, representing... See more

Pages